- Calvin McGinn, Ph.D., LMFT, RN, Founder & Principal Researcher
- Joyce Ann McGinn, OTR/L, GCFP, Co-Founder & COO
BIO: Compris is the only substance addiction assessment available today that offers comprehensive diagnostics and risk stratification consistent with a chronic illness treatment paradigm. Its 10,000 machine learning algorithms translate evidence-based lifetime risk and resilience factors, DSM-5 and Heaviness of Smoking Index (HSI) diagnostics, motivation, denial, and readiness, into the first complete prevention, treatment, and long-term addiction management guide. Compris’ innovative BUILD model, based on decades of research, captures lifetime addiction risk from a person’s Blueprint (genetics/epigenetics), User traits (i.e., Substance Use Risk Profile Scale), Injured developing brain, Life stress and trauma, and Damage from use.